A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study*†‡*Supported by Sandoz Pharma, Ltd.†Presented in part at the Joint Meeting of the European Society of Human Reproduction and Embryology and the European Sterility Congress Organization, Milan, Italy, August 31, 1990.‡The following investigators were participants in this French multicenter study: Philippe Jaquet, M.D., Marseille; Jean-Pierre Louvet, M.D., Toulouse; Didier Dewailly, M.D., Lille; Patrick Roger, M.D., Bordeaux; Jean-Louis Schlienger, M.D., Strasbourg; Gèrard Schaison, M.D., Paris; Pierre Hartemann, M.D., Nancy.
1992 ◽
Vol 57
(1)
◽
pp. 74-80
◽
Keyword(s):
2004 ◽
Vol 16
(6)
◽
pp. 319-325
◽
2018 ◽
Keyword(s):
2012 ◽
Vol 28
(3)
◽
pp. 475-491
◽
1987 ◽
Vol 111
(4)
◽
pp. 548-551
◽
Keyword(s):
Keyword(s):
1988 ◽
Vol 23
(1)
◽
pp. 135-135
◽
Keyword(s):